Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
Is a |
Ursodeoxycholic acid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
Is a |
Ursodeoxycholic acid-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Gallstone solubilizing agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ursodiol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ursodeoxycholic acid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bile |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
Has manufactured dose form |
Oral suspension (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|